期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
抗PD-1PD-L1单抗用于晚期非小细胞肺癌患者的疗效分析
1
作者 周冲 《西藏医药》 2024年第6期32-33,共2页
目的 探讨抗PD-1/PD-L1单抗在晚期非小细胞肺癌(NSCLC)患者中的治疗效果。方法 通过系统检索国内外公开发表的关于抗PD-1/PD-L1单抗治疗晚期NSCLC的临床研究文献。提取关键指标,包括生存期、疾病控制率。采用Meta分析方法,对数据进行统... 目的 探讨抗PD-1/PD-L1单抗在晚期非小细胞肺癌(NSCLC)患者中的治疗效果。方法 通过系统检索国内外公开发表的关于抗PD-1/PD-L1单抗治疗晚期NSCLC的临床研究文献。提取关键指标,包括生存期、疾病控制率。采用Meta分析方法,对数据进行统计。结果 在OS分析中,纳入的10项研究共涉及5515例晚期NSCLC患者,结果显示PD-1/PD-L1抑制剂联合化疗相比单纯化疗显著延长了OS,降低了26%的死亡风险。对于PFS,12项研究包含6090例患者,联合治疗组较对照组延长了PFS,降低了43%的疾病进展风险。在ORR方面,10项研究涉及5246例患者,联合治疗组显著提高了ORR,相比对照组差异显著。结论 通过Meta药学分析证实,抗PD-1/PD-L1单抗在晚期非小细胞肺癌治疗中具有良好的疗效和安全性,可为临床用药提供有力支持。 展开更多
关键词 抗PD-1/PD-L1单抗 晚期非小细胞肺癌 meta药学分析
下载PDF
Population pharmacokinetics of risperidone based on meta-analysis and its application in therapeutic drug monitoring of Chinese schizophrenic patients 被引量:2
2
作者 季双敏 尚德为 +6 位作者 王曦培 李安宁 任宇鹏 李良 周田彦 王传跃 卢炜 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第2期75-82,共8页
Population pharmacokinetic meta-analysis method was used in order to obtain the pharmacokinetic characteristics of risperidone and its active metabolite. Eighteen studies were selected from published papers from 1995 ... Population pharmacokinetic meta-analysis method was used in order to obtain the pharmacokinetic characteristics of risperidone and its active metabolite. Eighteen studies were selected from published papers from 1995 to 2011. A model consisted of two compartments for parent drug and one compartment for its active metabolite combined with a flexible absorption process was developed based on the meta-dataset. The population-predicted apparent clearance for risperidone and 9-hydroxyrisperidone, the active metabolite was 7.66 L/h and 7.38 L/h, and the apparent volume of distribution in the central compartment was 70.6 L and 117 L, respectively. The final model was evaluated by visual predictive check(VPC) based on 1000 times model simulation. This model was adequately used to predict clinical therapeutic drug monitoring(TDM) data from 42 Chinese inpatients. Bias(mean prediction errors, MPE) and precision(root mean squared prediction errors, RMSE) were calculated to statistically analysis the population prediction error. It was demonstrated that the model developed from the meta-dataset was reliable and can be used to facilitate the individualized treatment for a target population. 展开更多
关键词 meta-ANALYSIS Population pharmacokinetics RISPERIDONE 9-HYDROXYRISPERIDONE
原文传递
Meta-analysis on integrative medicine for the treatment of malignant ascites: a comparative study 被引量:5
3
作者 Li Yuan Lou Yanni +1 位作者 Deng Bo Jia Liqun 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2015年第1期11-14,共4页
OBJECTIVE: To compare the efficacy of integrated Chinese and Western Medicine with that of only Western Medicine for the treatment of malignant ascites.METHODS: All randomized controlled trials(January 2004 to March 2... OBJECTIVE: To compare the efficacy of integrated Chinese and Western Medicine with that of only Western Medicine for the treatment of malignant ascites.METHODS: All randomized controlled trials(January 2004 to March 2013) from the China National Knowledge Infrastructure Database, Chinese Biomedical Literature Database, and Wanfang Database were searched with keywords. Meta-analysis was conducted by combining the odds ratios of the individual studies. Review Manager 5.0 was used for the analysis.RESULTS: One thousand one hundred and fifty-six patients from 19 randomized controlled trails were included. Of them, 630 patients were treated with integrated Chinese and Western Medicine(the integrative group), and 526 patients were treated with Western Medicine alone(the control group). The Meta-analysis showed that the total effective rate was 78.73% in the integrated group, and 59.13% in the control group. The effective percentage was sig-nificantly higher in the integrative group than that of the control group [OR = 2.85, 95% CI(2.16,3.74),P < 0.01].CONCLUSION: The short-term curative effect in the integrative group was better than that in the control group. Integrative medicine may be beneficial for malignant ascites. 展开更多
关键词 ASCITES Integrative medicine Treat-ment outcome meta-ANALYSIS
原文传递
A validated HPLC method for the determination of donepezil in human plasma after derivatization with 9-fluorenylmethyl chloroformate 被引量:2
4
作者 Reza Ahmadkhaniha Abdolrahman Nazari +1 位作者 Mohsen Amini Effat Souri 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2014年第2期118-123,共6页
A new HPLC method has been developed for determining donepezil in human plasma. To find the optimum conditions, a derivatization reaction was performed in different media, and the reaction product was identified by NM... A new HPLC method has been developed for determining donepezil in human plasma. To find the optimum conditions, a derivatization reaction was performed in different media, and the reaction product was identified by NMR and GC-MS after a semi-preparative HPLC separation. Under optimized conditions, donepezil was derivatized by 9-fluorenylmethyl chloroformate in chloroform and carbonate buffer at pH 9.5 in the presence of NaI after solid-phase extraction from a plasma sample. The reaction product was quantified on a reversed-phase TRACER EXCEL ODS-A, 5 μm column using a mixture of acetonitrile–10 mM acetate buffer(pH 6.0)–THF(60:35:5, v/v/v) as the mobile phase with fluorescence detection at 264 nm(ex) and 313 nm(em). Fluoxetine was used as the internal standard. The total run-time of the analysis was about 10 min, and a clean chromatogram was obtained. The developed method was linear over the range of 1–100 ng/mL in 500 μL of plasma samples(r2>0.998). The intra-day and inter-day precision values were in the range of 2.6%–11.6%. The limit of quantification was 1 ng/mL. 展开更多
关键词 9-Fluorenylmethyl chloroformate DERIVATIZATION HPLC
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部